Anymedi Inc. announced a private placement of 500,000 convertible preferred stock at the price of KRW 4,000 per share for gross proceeds of KRW 2,000,000,000 on January 13, 2023. The transaction will include participation from High-Tech Technology Development Commercialization Fund No. 2. The company will issue convertible preferred stock through third party allocation method.

Post closing, the total number of convertible preferred stock issued will increase from 2,570,198 convertible preferred stock to 3,070,198 convertible preferred stock. The transaction has been approved by board of directors of the company. The payment date for the transaction is March 7, 2023.